US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 25.120
  • +0.210+0.84%
Close May 9 16:00 ET
  • 25.120
  • 0.0000.00%
Post 16:00 ET
1.16BMarket Cap-11.21P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
Net income from continuing operations
-46.41%4.81M
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
Operating gains losses
----
-144.42%-7.52M
--0
--0
----
----
--16.93M
--0
--0
--0
Depreciation and amortization
14.88%21.17M
4.25%78.79M
14.92%21.24M
9.87%20.25M
-1.00%18.86M
-6.00%18.43M
-17.41%75.57M
-39.21%18.49M
-8.74%18.43M
-8.68%19.05M
Deferred tax
-59.66%1.4M
32.06%20.62M
-46.86%3.51M
-77.31%1.12M
9.55%12.54M
147.17%3.46M
296.54%15.62M
160.89%6.6M
600.00%4.91M
428.74%11.44M
Other non cash items
-154.13%-7.7M
-52.62%1.17M
415.93%4.41M
-143.07%-2.54M
113.32%2.33M
-122.93%-3.03M
111.19%2.46M
121.19%854K
532.90%5.91M
11.14%-17.51M
Change In working capital
-84.91%1.22M
59.55%-18.52M
-55.52%-24.33M
125.46%2.09M
29.39%-4.39M
151.59%8.11M
-178.57%-45.78M
-608.93%-15.65M
-846.02%-8.2M
-19.06%-6.21M
-Change in receivables
118.51%8.56M
-8.23%-7.75M
-47.12%-12.65M
94.39%4.13M
46.54%-3.14M
-24.56%3.92M
-244.35%-7.16M
-74.56%-8.6M
189.73%2.12M
-688.68%-5.88M
-Change in inventory
-211.89%-8.47M
-152.46%-20.93M
-71.29%-13.42M
-91.96%-8.43M
-885.95%-6.66M
145.37%7.57M
-433.47%-8.29M
-1,165.71%-7.83M
-215.86%-4.39M
-72.45%847K
-Change in prepaid assets
-892.75%-7.11M
23.64%-7.36M
61.48%-1.02M
-92.17%-5.03M
9.70%-2.21M
146.57%897K
-257.13%-9.64M
-24.50%-2.65M
-198.20%-2.62M
-337.88%-2.44M
-Change in payables and accrued expense
304.45%7.17M
170.08%14.8M
-137.80%-1.15M
483.83%11.82M
444.02%7.64M
84.42%-3.51M
-55.49%-21.12M
-42.48%3.05M
39.60%-3.08M
113.09%1.4M
-Change in other current liabilities
240.34%1.08M
525.35%2.71M
892.13%3.91M
-70.17%-405K
86.71%-19K
-283.14%-771K
178.06%434K
133.42%394K
-265.28%-238K
-134.96%-143K
Cash from discontinued investing activities
Operating cash flow
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
Investing cash flow
Cash flow from continuing investing activities
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
Net PPE purchase and sale
-201.41%-8.55M
29.85%-10.64M
-17.80%-2.12M
-20.57%-4.09M
53.29%-1.59M
56.80%-2.84M
49.59%-15.16M
67.26%-1.8M
34.49%-3.39M
70.99%-3.4M
Net business purchase and sale
---16.7M
--0
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
97.01%-379K
-178.36%-72.64M
-82.80%1.75M
-4,970.78%-48.07M
-226.98%-13.63M
-117.45%-12.69M
156.83%92.7M
-39.02%10.17M
97.76%-948K
-65.27%10.73M
Cash from discontinued investing activities
Investing cash flow
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
Financing cash flow
Cash flow from continuing financing activities
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
Net issuance payments of debt
0.00%-2.81M
142.38%76.62M
0.00%-2.81M
89.89%-2.81M
3,123.57%85.05M
98.09%-2.81M
57.74%-180.76M
95.26%-2.81M
-196.66%-27.81M
98.31%-2.81M
Net common stock issuance
----
---25M
--0
--0
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
----
-51.62%2.3M
2,326.95%27.64M
-106,936.00%-26.71M
-58.07%1.36M
--0
-82.63%4.75M
-44.14%1.14M
-98.44%25K
-74.34%3.25M
Net other financing activities
-4,425.00%-181K
-420.73%-36.55M
-25,169.81%-26.79M
--26.68M
---36.44M
99.94%-4K
-497.36%-7.02M
---106K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
Net cash flow
Beginning cash position
80.55%276.77M
47.21%153.3M
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
-82.22%104.14M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
Current changes in cash
-77.77%6.84M
151.18%123.48M
-43.13%30.81M
-108.84%-1.09M
22.89%63M
144.83%30.75M
110.21%49.16M
1,125.15%54.18M
197.40%12.31M
148.97%51.27M
End cash Position
54.09%283.61M
80.55%276.77M
80.55%276.77M
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
47.21%153.3M
-9.42%99.12M
-28.88%86.81M
Free cash flow
-41.83%26.91M
28.15%178.75M
-32.26%31.01M
21.40%49.83M
28.81%51.65M
268.26%46.27M
21.09%139.49M
25.29%45.79M
9.53%41.04M
121.87%40.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M
Net income from continuing operations -46.41%4.81M-337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M
Operating gains losses -----144.42%-7.52M--0--0----------16.93M--0--0--0
Depreciation and amortization 14.88%21.17M4.25%78.79M14.92%21.24M9.87%20.25M-1.00%18.86M-6.00%18.43M-17.41%75.57M-39.21%18.49M-8.74%18.43M-8.68%19.05M
Deferred tax -59.66%1.4M32.06%20.62M-46.86%3.51M-77.31%1.12M9.55%12.54M147.17%3.46M296.54%15.62M160.89%6.6M600.00%4.91M428.74%11.44M
Other non cash items -154.13%-7.7M-52.62%1.17M415.93%4.41M-143.07%-2.54M113.32%2.33M-122.93%-3.03M111.19%2.46M121.19%854K532.90%5.91M11.14%-17.51M
Change In working capital -84.91%1.22M59.55%-18.52M-55.52%-24.33M125.46%2.09M29.39%-4.39M151.59%8.11M-178.57%-45.78M-608.93%-15.65M-846.02%-8.2M-19.06%-6.21M
-Change in receivables 118.51%8.56M-8.23%-7.75M-47.12%-12.65M94.39%4.13M46.54%-3.14M-24.56%3.92M-244.35%-7.16M-74.56%-8.6M189.73%2.12M-688.68%-5.88M
-Change in inventory -211.89%-8.47M-152.46%-20.93M-71.29%-13.42M-91.96%-8.43M-885.95%-6.66M145.37%7.57M-433.47%-8.29M-1,165.71%-7.83M-215.86%-4.39M-72.45%847K
-Change in prepaid assets -892.75%-7.11M23.64%-7.36M61.48%-1.02M-92.17%-5.03M9.70%-2.21M146.57%897K-257.13%-9.64M-24.50%-2.65M-198.20%-2.62M-337.88%-2.44M
-Change in payables and accrued expense 304.45%7.17M170.08%14.8M-137.80%-1.15M483.83%11.82M444.02%7.64M84.42%-3.51M-55.49%-21.12M-42.48%3.05M39.60%-3.08M113.09%1.4M
-Change in other current liabilities 240.34%1.08M525.35%2.71M892.13%3.91M-70.17%-405K86.71%-19K-283.14%-771K178.06%434K133.42%394K-265.28%-238K-134.96%-143K
Cash from discontinued investing activities
Operating cash flow -27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M
Investing cash flow
Cash flow from continuing investing activities -65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M
Net PPE purchase and sale -201.41%-8.55M29.85%-10.64M-17.80%-2.12M-20.57%-4.09M53.29%-1.59M56.80%-2.84M49.59%-15.16M67.26%-1.8M34.49%-3.39M70.99%-3.4M
Net business purchase and sale ---16.7M--0--------------0--0------------
Net investment purchase and sale 97.01%-379K-178.36%-72.64M-82.80%1.75M-4,970.78%-48.07M-226.98%-13.63M-117.45%-12.69M156.83%92.7M-39.02%10.17M97.76%-948K-65.27%10.73M
Cash from discontinued investing activities
Investing cash flow -65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M
Financing cash flow
Cash flow from continuing financing activities -6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K
Net issuance payments of debt 0.00%-2.81M142.38%76.62M0.00%-2.81M89.89%-2.81M3,123.57%85.05M98.09%-2.81M57.74%-180.76M95.26%-2.81M-196.66%-27.81M98.31%-2.81M
Net common stock issuance -------25M--0--0----------0--0--0----
Proceeds from stock option exercised by employees -----51.62%2.3M2,326.95%27.64M-106,936.00%-26.71M-58.07%1.36M--0-82.63%4.75M-44.14%1.14M-98.44%25K-74.34%3.25M
Net other financing activities -4,425.00%-181K-420.73%-36.55M-25,169.81%-26.79M--26.68M---36.44M99.94%-4K-497.36%-7.02M---106K--0--0
Cash from discontinued financing activities
Financing cash flow -6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K
Net cash flow
Beginning cash position 80.55%276.77M47.21%153.3M148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M-82.22%104.14M-9.42%99.12M-28.88%86.81M-84.32%35.55M
Current changes in cash -77.77%6.84M151.18%123.48M-43.13%30.81M-108.84%-1.09M22.89%63M144.83%30.75M110.21%49.16M1,125.15%54.18M197.40%12.31M148.97%51.27M
End cash Position 54.09%283.61M80.55%276.77M80.55%276.77M148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M47.21%153.3M-9.42%99.12M-28.88%86.81M
Free cash flow -41.83%26.91M28.15%178.75M-32.26%31.01M21.40%49.83M28.81%51.65M268.26%46.27M21.09%139.49M25.29%45.79M9.53%41.04M121.87%40.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +20.03%
Sample Name
Sample Code
 +19.99%
Sample Name
Sample Code
 +19.82%
4
QIFENG
873169
+17.45%
5
LAISAI LASER
871263
+17.14%
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 15.760
Sample Name
Sample Code
 298.260
Sample Name
Sample Code
 11.800
4
Ecopetrol
EC
8.160
5
Vale SA
VALE
9.360
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 298.260
Sample Name
Sample Code
 102.840
Sample Name
Sample Code
 105.940
4
Taiwan Semiconductor
TSM
176.520
5
Apple
AAPL
198.530
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 8.410
Sample Name
Sample Code
 3.110
Sample Name
Sample Code
 0.7486
4
MARA Holdings
MARA
15.760
5
CleanSpark
CLSK
9.200
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -